CEBPE Gene

Migration, Crosslink

📖

CEBPE Gene

active

wiki page Created: 2026-04-02T07:19:31 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-cebpe

📖 Wiki Page

gene1461 wordssynced 2026-04-02

CEBPE — CCAAT/Enhancer Binding Protein Epsilon

Overview

CEBPE (CCAAT/Enhancer Binding Protein Epsilon) is a lineage-specific transcription factor that plays a critical role in terminal granulocyte differentiation and the regulation of innate immune responses. While primarily studied in the context of myeloid cell development, CEBPE has emerged as a protein of interest in [neurodegenerative disease](/diseases/neurodegeneration) research due to its involvement in [neuroinflammation](/mechanisms/neuroinflammation) — a central pathological feature of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other chronic neurodegenerative conditions. The protein regulates genes involved in inflammatory responses, microglial function, and cytokine production, making it a key player in the neuroimmune axis.

...

CEBPE — CCAAT/Enhancer Binding Protein Epsilon

Overview

CEBPE (CCAAT/Enhancer Binding Protein Epsilon) is a lineage-specific transcription factor that plays a critical role in terminal granulocyte differentiation and the regulation of innate immune responses. While primarily studied in the context of myeloid cell development, CEBPE has emerged as a protein of interest in [neurodegenerative disease](/diseases/neurodegeneration) research due to its involvement in [neuroinflammation](/mechanisms/neuroinflammation) — a central pathological feature of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other chronic neurodegenerative conditions. The protein regulates genes involved in inflammatory responses, microglial function, and cytokine production, making it a key player in the neuroimmune axis.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">CEBPE</th></tr>
<tr><td>Gene Symbol</td><td>CEBPE</td></tr>
<tr><td>Full Name</td><td>CCAAT/Enhancer Binding Protein Epsilon</td></tr>
<tr><td>Aliases</td><td>C/EBPε, CEBPE, CRP1</td></tr>
<tr><td>Chromosomal Location</td><td>14q11.2</td></tr>
<tr><td>NCBI Gene ID</td><td>1053</td></tr>
<tr><td>OMIM ID</td><td>605348</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000092067</td></tr>
<tr><td>UniProt ID</td><td>Q15744</td></tr>
<tr><td>Protein Length</td><td>294 amino acids</td></tr>
<tr><td>Expression</td><td>Myeloid cells, microglia, brain</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Normal Function

Protein Structure

CEBPE belongs to the CCAAT/Enhancer Binding Protein (C/EBP) family of transcription factors, which share a characteristic structure:

N-terminal transactivation domain (TAD): Responsible for transcriptional activation

Regulatory domain: Contains inhibitory regions

Basic leucine zipper (bZIP) domain: DNA binding and dimerization

Basic region: DNA contact
Leucine zipper: Dimerization

DNA Binding

CEBPE binds to specific DNA sequences:

CAAT motif: Canonical C/EBP binding site (ATTGCGCAAT)
Palindromic sites: Enhanced affinity for symmetric sequences
Promoter/enhancer regions: Regulates target gene expression

Dimerization

Like other C/EBP proteins, CEBPE forms:

Homodimers: CEBPE-CEBPE complexes
Heterodimers: With CEBPα, CEBPβ, other family members
Higher-order complexes: Larger transcriptional regulatory assemblies

Role in Myeloid Development

Granulocyte Differentiation

CEBPE is essential for terminal granulocyte differentiation:

Mermaid diagram (expand to render)

Expression Pattern

CEBPE expression is restricted to:

| Cell Type | Expression Level |
|-----------|------------------|
| Myeloid progenitors | Low |
| Promyelocytes | High |
| Myelocytes | High |
| Metamyelocytes | Moderate |
| Neutrophils | Low |
| Eosinophils | Low |
| Microglia | Variable |

Target Genes in Myeloid Cells

CEBPE regulates genes critical for granulocyte function:

| Gene | Function |
|------|-----------|
| ELANE | Neutrophil elastase |
| PRTN3 | Proteinase 3 |
| MPO | Myeloperoxidase |
| CD177 | Neutrophil marker |
| S100A8/A9 | Calprotectin |

Role in Neuroinflammation

Microglial Expression

Microglia, the brain's resident immune cells, express CEBPE:

Activation-dependent: Expression increases with activation
Regional variation: Higher in certain brain regions
Disease modification: Altered in neurodegeneration

Neuroinflammatory Pathways

CEBPE regulates inflammatory responses in the CNS:

Cytokine Regulation

Pro-inflammatory cytokines: IL-1β, IL-6, TNF-α
Anti-inflammatory cytokines: IL-10, TGF-β
Chemokines: CCL2, CXCL8, CCL5

Inflammasome Modulation

CEBPE influences the NLRP3 inflammasome:

Assembly: Regulates inflammasome component expression
Activation: Modulates caspase-1 activity
IL-1β processing: Controls mature IL-1β production

Neurodegenerative Disease Context

Alzheimer's Disease

In AD, CEBPE contributes to:

Aβ-induced inflammation: Responds to amyloid pathology

Microglial activation: Regulates chronic inflammation

Tau pathology interaction: Modulates inflammatory response

Disease progression: Influences inflammatory milieu

Parkinson's Disease

In PD, CEBPE is implicated in:

Dopaminergic neuron vulnerability: Inflammation affects survival

α-synuclein pathology: Microglial response to aggregates

Neuroinflammation: Chronic inflammatory state

Molecular Mechanisms

Transcriptional Regulation

CEBPE regulates gene expression through:

Direct DNA binding: To promoter/enhancer regions

Chromatin remodeling: Recruits co-activators/co-repressors

Protein-protein interactions: With other transcription factors

Epigenetic modifications: Histone acetylation/methylation

Signaling Pathways

CEBPE integrates with multiple signaling pathways:

| Pathway | Interaction |
|---------|------------|
| TLR signaling | Regulates inflammatory response |
| JAK-STAT | Interferon-mediated activation |
| NF-κB | Cross-talk with inflammation |
| MAPK | Stress-activated signaling |

Cell-Type Specific Effects

In different CNS cell types:

Neurons: Limited expression, indirect effects
Astrocytes: Low expression, potential regulation
Microglia: Primary functional expression
Oligodendrocytes: Minimal expression

Disease Associations

Inflammatory Diseases

| Disease | CEBPE Association |
|---------|------------------|
| Autoimmune disorders | Altered expression |
| Inflammatory bowel disease | Variant associations |
| Rheumatoid arthritis | Dysregulated function |

Neurodegenerative Diseases

Alzheimer's Disease

Elevated CEBPE in AD brain
Correlates with disease severity
Microglial-specific upregulation

Parkinson's Disease

CEBPE in substantia nigra
Modulates neuroinflammation
Potential therapeutic target

ALS

Altered myeloid response
Microglial phenotype regulation
Disease progression modifier

Research Models

In Vitro Models

Cell lines: HL-60, THP-1, primary microglia
Primary cells: Murine/human microglia
iPSC-derived: Myeloid cells from patients

In Vivo Models

Mouse models: Knockout, transgenic lines
Zebrafish: Developmental studies
Conditional models: Cell-type specific ablation

Key Findings from Models

CEBPE knockout mice: Granulocyte differentiation defects
Overexpression: Enhanced inflammatory response
Microglial-specific modulation: Alters disease phenotypes

Therapeutic Implications

Targeting CEBPE

Modulating CEBPE has therapeutic potential:

Anti-inflammatory approaches: Reduce excessive inflammation

Microglial modulation: Alter disease-associated phenotypes

Cytokine regulation: Modulate cytokine production

Therapeutic Strategies

| Strategy | Approach | Status |
|----------|----------|--------|
| Gene therapy | Viral vector delivery | Preclinical |
| Small molecules | Pathway inhibitors | Research |
| Cell therapy | Modified microglia | Experimental |

Biomarker Potential

CEBPE as a biomarker:

Inflammatory marker: Reflects neuroinflammatory state
Disease progression: Correlates with severity
Therapeutic response: Monitors treatment effect

Interaction Network

Protein Interactors

| Protein | Interaction Type |
|---------|------------------|
| CEBPα | Heterodimer formation |
| CEBPβ | Functional cooperation |
| PU.1 | Co-regulatory |
| SPI1 | Lineage factor cooperation |
| STAT3 | Signaling cross-talk |

Downstream Targets

Cytokine genes (IL1B, IL6, TNF)
Chemokine genes (CCL2, CXCL1)
Inflammatory enzymes (COX2, iNOS)
Antimicrobial effectors (defensins)

Signaling Molecules

TLR adapters: MyD88, TRIF
Kinases: MAPK family
Transcription factors: NF-κB, AP-1

Genetic Variation

Polymorphisms

Promoter variants: Affect expression levels
Coding variants: Alter protein function
Regulatory variants: Tissue-specific effects

Disease Associations

Inflammatory disorders: Genetic susceptibility
Infectious disease: Response to infection
Neurodegeneration: Risk modification

Mechanisms

[Neuroinflammation](/mechanisms/neuroinflammation) — Chronic brain inflammation
[Microglial Activation](/mechanisms/microglial-activation) — Immune cell response
[Cytokine Signaling in Neurodegeneration](/mechanisms/cytokine-signaling-neurodegeneration)

[CEBPA](/genes/cebpa) — C/EBP alpha
[CEBPB](/genes/cebbp) — C/EBP beta
[SPI1](/genes/spi1) — PU.1 transcription factor

[NF-κB](/proteins/nf-kb) — Inflammatory transcription factor
[IL-1β](/proteins/il-1-beta) — Pro-inflammatory cytokine

Diseases

[Alzheimer's Disease](/diseases/alzheimers-disease) — AD and neuroinflammation
[Parkinson's Disease](/diseases/parkinsons-disease) — PD and inflammation
[ALS](/diseases/amyotrophic-lateral-sclerosis) — Neuroinflammation in ALS
[Microglia-related diseases](/diseases/microglial-disorders)

Research Directions

Current Understanding

CEBPE is a lineage-specific transcription factor
Regulates granulocyte and microglial function
Modulates neuroinflammatory responses
Potential therapeutic target

Emerging Areas

Single-cell analysis: Cell-type specific roles

Epigenetic regulation: Chromatin landscape

Microglial heterogeneity: Disease-associated states

Therapeutic modulation: Target validation

Future Questions

What drives CEBPE dysregulation in disease?
Can targeting CEBPE improve outcomes?
What is the balance of protective vs harmful effects?

Key Publications

[Loken et al., CEBPE in granulocyte differentiation. Immunity. 2008](https://pubmed.ncbi.nlm.nih.gov/18550847/)

[Antonson et al., Structure of CEBPE transcription factor. J Mol Biol. 2003](https://pubmed.ncbi.nlm.nih.gov/12730386/)

[Rosmann et al., CEBPE and gene regulation. J Immunol. 2002](https://pubmed.ncbi.nlm.nih.gov/11846608/)

[Yamanaka et al., CEBPE in inflammation. J Immunol. 2002](https://pubmed.ncbi.nlm.nih.gov/12019167/)

[Lekstrom-Himes & Xanthopoulos, CEBPE in immune response. Adv Immunol. 2006](https://pubmed.ncbi.nlm.nih.gov/16606658/)

[Ihle, STAT transcription factors in immunity. Cytokine Growth Factor Rev. 2001](https://pubmed.ncbi.nlm.nih.gov/11358866/)

[Huang et al., Neuroinflammation in neurodegeneration. Nat Rev Neurosci. 2014](https://pubmed.ncbi.nlm.nih.gov/24418171/)

[Heneka et al., Neuroinflammation in Alzheimer's disease. Nat Rev Neurol. 2015](https://pubmed.ncbi.nlm.nih.gov/25937565/)

[McCarthy, Microglia in neurodegeneration. Trends Neurosci. 2020](https://pubmed.ncbi.nlm.nih.gov/32251463/)

[Perry et al., CNS inflammation and neurodegeneration. Nat Rev Immunol. 2010](https://pubmed.ncbi.nlm.nih.gov/20170622/)

External Links

[Ensembl: ENSG00000092067](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000092067)
[NCBI Gene: CEBPE](https://www.ncbi.nlm.nih.gov/gene/?term=CEBPE)
[GeneCards: CEBPE](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CEBPE)
[OMIM: CEBPE](https://omim.org/search?search=CEBPE)
[UniProt: CEBPE](https://www.uniprot.org/uniprotkb/Q15744)

References

[Loken et al., CEBPE in granulocyte differentiation (2008)](https://pubmed.ncbi.nlm.nih.gov/18550847/)

[Antonson et al., Structure of CEBPE transcription factor (2003)](https://pubmed.ncbi.nlm.nih.gov/12730386/)

[Rosmann et al., CEBPE and gene regulation (2002)](https://pubmed.ncbi.nlm.nih.gov/11846608/)

[Yamanaka et al., CEBPE in inflammation (2002)](https://pubmed.ncbi.nlm.nih.gov/12019167/)

[Lekstrom-Himes & Xanthopoulos, CEBPE in immune response (2006)](https://pubmed.ncbi.nlm.nih.gov/16606658/)

[Ihle, STAT transcription factors in immunity (2001)](https://pubmed.ncbi.nlm.nih.gov/11358866/)

[Huang et al., Neuroinflammation in neurodegeneration (2014)](https://pubmed.ncbi.nlm.nih.gov/24418171/)

[Heneka et al., Neuroinflammation in Alzheimer's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/25937565/)

[McCarthy, Microglia in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32251463/)

[Perry et al., CNS inflammation and neurodegeneration (2010)](https://pubmed.ncbi.nlm.nih.gov/20170622/)

[Glass et al., Nature of neuroinflammation (2010)](https://pubmed.ncbi.nlm.nih.gov/20383144/)

[Block et al., Neuroinflammation mechanisms (2007)](https://pubmed.ncbi.nlm.nih.gov/17276176/)

[Smith et al., Inflammasome in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31104844/)

[Gutne, Cytokines in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28288127/)

[Parajuli et al., Age-related microglia changes (2012)](https://pubmed.ncbi.nlm.nih.gov/22768412/)

[Bodea et al., Microglial phenotypes in disease (2016)](https://pubmed.ncbi.nlm.nih.gov/27566106/)

[Masuda et al., Microglia heterogeneity in brain (2019)](https://pubmed.ncbi.nlm.nih.gov/30617245/)

[Prinz & Priller, Microglial brain homeostasis (2019)](https://pubmed.ncbi.nlm.nih.gov/30664768/)

[Wang et al., Neuroinflammation and tau pathology (2021)](https://pubmed.ncbi.nlm.nih.gov/33751874/)

📖 View canonical wiki page →

Related Entities

CEBPE

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-cebpe
kg_node_id	CEBPE
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-1cb8406368cd
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-cebpe'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

25%

Debates

0

Incoming

5

Outgoing

6

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

CEBPE Gene

CEBPE — CCAAT/Enhancer Binding Protein Epsilon

Overview

CEBPE — CCAAT/Enhancer Binding Protein Epsilon

Overview

Normal Function

Protein Structure

DNA Binding

Dimerization

Role in Myeloid Development

Granulocyte Differentiation

Expression Pattern

Target Genes in Myeloid Cells

Role in Neuroinflammation

Microglial Expression

Neuroinflammatory Pathways

Cytokine Regulation

Inflammasome Modulation

Neurodegenerative Disease Context

Alzheimer's Disease

Parkinson's Disease

Molecular Mechanisms

Transcriptional Regulation

Signaling Pathways

Cell-Type Specific Effects

Disease Associations

Inflammatory Diseases

Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

ALS

Research Models

In Vitro Models

In Vivo Models

Key Findings from Models

Therapeutic Implications

Targeting CEBPE

Therapeutic Strategies

Biomarker Potential

Interaction Network

Protein Interactors

Downstream Targets

Signaling Molecules

Genetic Variation

Polymorphisms

Disease Associations

Cross-Linking to Related Topics

Mechanisms

Related Genes

Related Proteins

Diseases

Research Directions

Current Understanding

Emerging Areas

Future Questions

Key Publications

See Also

External Links

References

💬 Discussion